Common Contracts

11 similar Common Share Warrant Agreement contracts by Milestone Pharmaceuticals Inc., Repare Therapeutics Inc., Sophiris Bio Inc., others

REPARE THERAPEUTICS INC. AND _____________, AS WARRANT AGENT FORM OF COMMON SHARE WARRANT AGREEMENT DATED AS OF __________
Common Share Warrant Agreement • August 6th, 2024 • Repare Therapeutics Inc. • Pharmaceutical preparations • New York

THIS COMMON SHARE WARRANT AGREEMENT (this “Agreement”), dated as of [•], between REPARE THERAPEUTICS INC., a corporation existing under the laws of the province of Québec (the “Company”), and [•], a [corporation] [national banking association] organized and existing under the laws of [•] and having a corporate trust office in [•], as warrant agent (the “Warrant Agent”).

AutoNDA by SimpleDocs
AS WARRANT AGENT FORM OF COMMON SHARE WARRANT AGREEMENT DATED AS OF __________ TERRASCEND CORP. FORM OF COMMON SHARE WARRANT AGREEMENT
Common Share Warrant Agreement • April 4th, 2024 • TerrAscend Corp. • Agricultural production-crops • New York

THIS COMMON SHARE WARRANT AGREEMENT (this “Agreement”), dated as of [•], between TERRASCEND CORP., a corporation existing under the laws of the Province of Ontario (the “Company”), and [•], a [corporation] [national banking association] organized and existing under the laws of [•] and having a corporate trust office in [•], as warrant agent (the “Warrant Agent”).

Milestone Pharmaceuticals Inc. and _____________, As Warrant Agent Form of Common Share Warrant Agreement Dated As Of __________ Milestone Pharmaceuticals Inc. Form of Common Share Warrant Agreement
Common Share Warrant Agreement • November 12th, 2021 • Milestone Pharmaceuticals Inc. • Pharmaceutical preparations • New York

This Common Share Warrant Agreement (this “Agreement”), dated as of [●], between MILESTONE PHARMACEUTICALS INC., a corporation existing under the laws of the province of Québec (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).

REPARE THERAPEUTICS INC. AND _____________, AS WARRANT AGENT FORM OF COMMON SHARE WARRANT AGREEMENT DATED AS OF __________
Common Share Warrant Agreement • July 2nd, 2021 • Repare Therapeutics Inc. • Pharmaceutical preparations • New York

THIS COMMON SHARE WARRANT AGREEMENT (this “Agreement”), dated as of [•], between REPARE THERAPEUTICS INC., a corporation existing under the laws of the province of Québec (the “Company”), and [•], a [corporation] [national banking association] organized and existing under the laws of [•] and having a corporate trust office in [•], as warrant agent (the “Warrant Agent”).

Lineage Cell Therapeutics, Inc. and ________, As Warrant Agent Form of Common Share Warrant Agreement Dated as of _____________
Common Share Warrant Agreement • March 11th, 2021 • Lineage Cell Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York

This Common Share Warrant Agreement (this “Agreement”), dated as of __________between Lineage Cell Therapeutics, Inc., a California corporation (the “Company”) and _________, a [corporation] [national banking association] organized and existing under the laws of __________ and having a corporate trust office in ________ , as warrant agent (the “Warrant Agent”).

Milestone Pharmaceuticals Inc. and _____________, As Warrant Agent Form of Common Share Warrant Agreement Dated As Of __________
Common Share Warrant Agreement • June 19th, 2020 • Milestone Pharmaceuticals Inc. • Pharmaceutical preparations • New York

This Common Share Warrant Agreement (this “Agreement”), dated as of [●], between MILESTONE PHARMACEUTICALS INC., a corporation existing under the laws of the province of Québec (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).

AXOVANT GENE THERAPIES LTD. and , AS WARRANT AGENT FORM OF COMMON SHARE WARRANT AGREEMENT DATED AS OF
Common Share Warrant Agreement • January 10th, 2020 • Axovant Gene Therapies Ltd. • Pharmaceutical preparations • New York

COMMON SHARE WARRANT AGREEMENT (this “Agreement”), dated as of between AXOVANT GENE THERAPIES LTD., a Bermuda Exempted Limited Company (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).

MYOVANT SCIENCES LTD. and , AS WARRANT AGENT FORM OF COMMON SHARE WARRANT AGREEMENT DATED AS OF
Common Share Warrant Agreement • November 13th, 2017 • Myovant Sciences Ltd. • Pharmaceutical preparations • New York

COMMON SHARE WARRANT AGREEMENT (this “Agreement”), dated as of between MYOVANT SCIENCES LTD., a Bermuda Exempted Limited Company (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).

SOPHIRIS BIO INC. and ________, AS WARRANT AGENT FORM OF COMMON SHARE WARRANT AGREEMENT DATED AS OF [__], 20___
Common Share Warrant Agreement • August 10th, 2017 • Sophiris Bio Inc. • Pharmaceutical preparations • New York

Common Share Warrant Agreement (this “Agreement”), dated as of between Sophiris Bio Inc. (the “Company”), and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).

AXOVANT SCIENCES LTD. and , AS WARRANT AGENT FORM OF COMMON SHARE WARRANT AGREEMENT DATED AS OF
Common Share Warrant Agreement • December 30th, 2016 • Axovant Sciences Ltd. • Pharmaceutical preparations • New York

COMMON SHARE WARRANT AGREEMENT (this “Agreement”), dated as of between AXOVANT SCIENCES LTD., a Bermuda Exempted Limited Company (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).

SOPHIRIS BIO INC. and ________, AS WARRANT AGENT FORM OF COMMON SHARE WARRANT AGREEMENT DATED AS OF [__], 20___
Common Share Warrant Agreement • September 16th, 2014 • Sophiris Bio Inc. • Pharmaceutical preparations • New York

Common Share Warrant Agreement (this “Agreement”), dated as of between Sophiris Bio Inc. (the “Company”), and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!